Things are happening. Results are coming, although _extended_ to clarify the non-seasonal flu skew. Meanwhile, The team won't just be sitting around waiting. They could be working on respiratory management, like a past annoucement indicated. There could be a number of left field annoucements coming, but I don't expect them to come before the FDA submission annoucement. Why you ask?
The main reason for not coming back with results: Don't detract away from the very important milestone of collecting results for FDA submission. For example: Releasing non-related results now would set our expectations, which may have different variables and may not be a clear comparison. Re-read the announcement, 'on track'... 'topline results'. It's close to being completed.
I've done quite a lot of work with machine learning as part of my job. I'm not concerned about the technology. I believe these guys know what they're doing.
Just my thoughts.
D.
RAP Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
